Human PBMCs were infected with VZV as described in Fig 1, then uninfected- and VZV-infected monocytes, NK cells, NKT cells, B cells, CD4+ T cells and CD8+ T cells were sorted using flow cytometry. RNA was harvested and then analyzed by quantitative RT-PCR for ORF63 (grey bars), ORF68 (red bars) and GAPdH (green bars) transcripts. In addition, VZV-infected HFLs that were >90% VZV gE+ based upon flow cytometry analyses were harvested as a positive control for viral transcript expression. Results representative of sorted PBMCs from 3 different healthy individuals and from 3 independent HFL infections, with bar graphs representing average 1/Ct ± SD. Dotted line represents threshold for Ct values (1/36). All immune cell populations were >93% pur...
<p>Quantitative PCR analysis was performed on RNA prepared from sorted cells from peripheral blood o...
<p>Two independent NHNP TLAs were established, infected with v63G/70R and sampled at indicated times...
<p>p.i: post-infection; NA: non activated PBMCs; A: activated PBMCs; MOI: multiplicity of infection....
Human PBMCs were co-cultured with VZV-infected HFLs for 48 h, then VZV-infected monocytes, NK, NKT, ...
(A) Human PBMCs were co-cultured with uninfected- (UI) or VZV-infected HFLs for 48 h then harvested ...
<p>Healthy human donor PBMCs were inoculated with mock or VZV infected ARPE-19 epithelial cells for ...
(A) HBVAFs were uninfected- (UI) or VZV-infected (V+) for 72 h and then cultured alone or with VZV O...
Human PBMCs from Fig 4 were co-cultured with uninfected- or VZV-infected HFLs for 48 h as described ...
<p>CD3<sup>–</sup>CD56<sup>+</sup>CD57<sup>–</sup> NK cells and CD3<sup>–</sup>CD56<sup>+</sup>CD57<...
<p>(A) Healthy human donor PBMCs were infected with VZV by cell-associated infection with or without...
<p>Healthy human donor PBMCs were mock or VZV infected with or without IL-2 (200 U/ml) for 2 days th...
VZV ORF34- or ORF18-specific CD8+ T cells were co-cultured with uninfected- or VZV-infected HFLs/HBV...
<p>(<b>A</b>) Representative analysis of PBMCs from infected and control subjects. Lymphocytes were ...
<p>NK cells (CD3<sup>–</sup>CD56<sup>+</sup>) were FACS sorted from healthy human donor CD56<sup>+</...
mDCs were infected with MOPV or LASV (MOI = 1) or were uninfected and cultured with T cells for 1, 2...
<p>Quantitative PCR analysis was performed on RNA prepared from sorted cells from peripheral blood o...
<p>Two independent NHNP TLAs were established, infected with v63G/70R and sampled at indicated times...
<p>p.i: post-infection; NA: non activated PBMCs; A: activated PBMCs; MOI: multiplicity of infection....
Human PBMCs were co-cultured with VZV-infected HFLs for 48 h, then VZV-infected monocytes, NK, NKT, ...
(A) Human PBMCs were co-cultured with uninfected- (UI) or VZV-infected HFLs for 48 h then harvested ...
<p>Healthy human donor PBMCs were inoculated with mock or VZV infected ARPE-19 epithelial cells for ...
(A) HBVAFs were uninfected- (UI) or VZV-infected (V+) for 72 h and then cultured alone or with VZV O...
Human PBMCs from Fig 4 were co-cultured with uninfected- or VZV-infected HFLs for 48 h as described ...
<p>CD3<sup>–</sup>CD56<sup>+</sup>CD57<sup>–</sup> NK cells and CD3<sup>–</sup>CD56<sup>+</sup>CD57<...
<p>(A) Healthy human donor PBMCs were infected with VZV by cell-associated infection with or without...
<p>Healthy human donor PBMCs were mock or VZV infected with or without IL-2 (200 U/ml) for 2 days th...
VZV ORF34- or ORF18-specific CD8+ T cells were co-cultured with uninfected- or VZV-infected HFLs/HBV...
<p>(<b>A</b>) Representative analysis of PBMCs from infected and control subjects. Lymphocytes were ...
<p>NK cells (CD3<sup>–</sup>CD56<sup>+</sup>) were FACS sorted from healthy human donor CD56<sup>+</...
mDCs were infected with MOPV or LASV (MOI = 1) or were uninfected and cultured with T cells for 1, 2...
<p>Quantitative PCR analysis was performed on RNA prepared from sorted cells from peripheral blood o...
<p>Two independent NHNP TLAs were established, infected with v63G/70R and sampled at indicated times...
<p>p.i: post-infection; NA: non activated PBMCs; A: activated PBMCs; MOI: multiplicity of infection....